Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.
Dr. Grannis on patient identity management at FDA panel

Patient identity management is a gaping hole in the American electronic healthcare system, one that needs to be addressed to improve the quality of real-world data according to Regenstrief Institute research scientist Shaun Grannis, M.D. He was one of several experts participating in a recent conference in Washington, D.C. to inform the U.S. Food and Drug Administration’s (FDA) use of real-world data and evidence to support its regulatory decisions.

The FDA is required by law to create a program to use real-world evidence. Scientists at the conference explored issues addressed in the FDA’s framework for creating that program.

Dr.  Grannis, the director of the Center for Biomedical Informatics at Regenstrief Institute, spoke in a session about curating and assessing data from electronic health records. He highlighted the need to adopt standards and common practices to improve patient identity management.

Our challenge is that standards are like toothbrushes. Everybody has one, but nobody wants to use someone else’s.

“Our challenge is that standards are like toothbrushes,” Dr. Grannis said. “Everybody has one, but nobody wants to use someone else’s. We now know that standardizing demographic data improves the accuracy of patient record matching and the overall quality of data. Now is the time to advance common approaches.”

Dr. Grannis cited a study from Regenstrief, Indiana University School of Medicine, Indiana University Richard M. Fairbanks School of Public Health at IUPUI and the Pew Charitable Trusts demonstrating that standardizing the format of last names and addresses can improve health record linkage by as much as 8 percent, which is equal to more than 2 billion records. He also spoke about the burgeoning effort to begin introduction of an expectation of standard practices for recording patient information.

Other panels at the conference discussed how to foster an ecosystem that facilitates the collection and generation of high-quality data and leveraging patient-generated health data.

The conference was funded by the FDA through a cooperative agreement with the Duke-Margolis Center for Health Policy.

Watch Dr. Grannis’ presentation:

In addition to his role at Regenstrief, Dr. Grannis is the Clem McDonald Professor of Biomedical Informatics and professor of family medicine at Indiana University School of Medicine.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Sep 20, 2021 • News
Ethical challenge of healthcare for undocumented immigrants yields clinician moral distress
In one of the first studies to explore clinician moral distress related to the ethically challenging provision of healthcare to undocumented immigrants, researchers from Regenstrief Institute and Indiana University School of Medicine surveyed physicians and nurses to assess their perspectives on treating end-stage renal disease in undocumented immigrants, a condition which Medicare covers for U.S.…
Continue Reading >
Sep 16, 2021 • News
Regenstrief Institute CEO to depart for Vanderbilt University
Peter Embí, M.D., M.S., president and CEO of the Regenstrief Institute, Inc., will leave the institute in December to assume the position of chair of Vanderbilt University Medical Center’s Department of Biomedical Informatics. He also will serve as senior vice president for research and innovation, a newly created position. He will join the Vanderbilt faculty…
Continue Reading >